The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PAPILLOPHAR: Impact of the human papillomavirus (HPV) status in the prognosis of oropharynx squamous cell carcinoma (OSCC).
J. Lacau Saint Guily
No relevant relationships to disclose
J. Pretet
No relevant relationships to disclose
G. Agius
No relevant relationships to disclose
A. Rousseau
No relevant relationships to disclose
B. Barry
No relevant relationships to disclose
X. Dufour
No relevant relationships to disclose
S. Perie
No relevant relationships to disclose
M. Lefevre
No relevant relationships to disclose
P. Birembaut
No relevant relationships to disclose
C. Mougin
No relevant relationships to disclose
T. Simon
No relevant relationships to disclose
C. Clavel
Expert Testimony - Roche
Other Remuneration - Sanofi